VENTIRX PHARMACEUTICALS INC

Profile

Company Names

VENTIRX PHARMACEUTICALS INC
VENTIRX PHARMACEUTICALS INC.

Addresses

1191 SECOND AVE., SUITE 1105, SEATTLE, WA 98101

1700 SEVENTH AVE., SUITE 1900, SEATTLE, WA 98101

12651 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO, CA 92130

Phone Numbers

(858) 436-1530
(206) 689-2259

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$65,602,514.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2014-09-22 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
1
2010-01-08 
$50,602,514.00 
$53,102,414.00 
$2,499,900.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KATHLEEN 
 
FANNING 
EXECUTIVE OFFICER
VENTIRX PHARMACEUTICALS INC.   |  NOHLA THERAPEUTICS INC.   |  EGENESIS, INC.
STEVEN 
 
GILLIS, PH.D. 
DIRECTOR
VENTIRX PHARMACEUTICALS INC   |  VENTIRX PHARMACEUTICALS INC.
ELLIOT 
 
GROSSBARD, M.D. 
DIRECTOR
VENTIRX PHARMACEUTICALS INC   |  VENTIRX PHARMACEUTICALS INC.
PATRICK 
 
HERON 
DIRECTOR
QUATRX PHARMACEUTICALS CO   |  TRUBION PHARMACEUTICALS, INC   |  COLLEGIUM PHARMACEUTICAL INC   |  VENTIRX PHARMACEUTICALS INC   |  TOBIRA THERAPEUTICS, INC.   |  KALIDEX PHARMACEUTICALS, INC.   |  PRECISION DERMATOLOGY, INC.   |  INFORMED MEDICAL COMMUNICATIONS, INC.   |  SILVERGATE PHARMACEUTICALS, INC.   |  VENTIRX PHARMACEUTICALS INC.   |  FRAZIER HEALTHCARE VII-A, L.P.   |  FRAZIER HEALTHCARE VII, L.P.   |  K2 THERAPEUTICS, INC.   |  IMAGO BIOSCIENCES, INC.   |  COLLEGIUM PHARMACEUTICAL, INC   |  CIDARA THERAPEUTICS, INC.   |  NEXCIDA THERAPEUTICS, INC.   |  ITERUM THERAPEUTICS LTD   |  ZAVANTE THERAPEUTICS, INC.   |  SUTROVAX, INC.   |  SCOUT BIO, INC.   |  RECIDA THERAPEUTICS, INC.   |  MIRUM PHARMACEUTICALS, INC.   |  PASSAGE BIO, INC.   |  ARCUTIS BIOTHERAPEUTICS, INC.   |  MBX BIOSCIENCES, INC.
ROBERT 
M. 
HERSHBERG, M.D., PH.D. 
EXECUTIVE OFFICER, DIRECTOR
VENTIRX PHARMACEUTICALS INC   |  VENTIRX PHARMACEUTICALS INC.
MICHAEL 
J. 
KAMDAR 
EXECUTIVE OFFICER, DIRECTOR
VENTIRX PHARMACEUTICALS INC   |  GENOA PHARMACEUTICALS, INC.   |  MOLECULAR ASSEMBLIES, INC.
RON 
 
LAUFER 
DIRECTOR
SYNOVEX CORP   |  CATABASIS PHARMACEUTICALS INC   |  G1 THERAPEUTICS, INC.   |  VENTIRX PHARMACEUTICALS INC.   |  ADHERON THERAPEUTICS, INC.
MAGGIE 
FLANAGAN 
LEFLORE, PH.D. 
DIRECTOR
VENTIRX PHARMACEUTICALS INC
ATUL 
 
SARAN 
DIRECTOR
INOTEK PHARMACEUTICALS CORP   |  VENTIRX PHARMACEUTICALS INC.   |  XENCOR INC   |  EMERGENT BIOSOLUTIONS INC.   |  PRONIRAS CORP
KENT 
 
SNYDER 
DIRECTOR
VENTIRX PHARMACEUTICALS INC   |  VENTIRX PHARMACEUTICALS INC.
NICOLE 
 
VITULLO 
DIRECTOR
MARINUS PHARMACEUTICALS INC   |  DP VIII ASSOCIATES, L.P.   |  DOMAIN PARTNERS VIII, L.P.   |  VENTIRX PHARMACEUTICALS INC   |  ESPERION THERAPEUTICS, INC.   |  CELATOR PHARMACEUTICALS INC   |  ABREXA PHARMACEUTICALS, INC.   |  VENTIRX PHARMACEUTICALS INC.   |  DOMAIN PARTNERS IX, L.P.   |  CELTAXSYS, INC.   |  COTERA, INC.   |  EXALYS THERAPEUTICS, INC.   |  ANTIOS THERAPEUTICS INC.   |  MARINUS PHARMACEUTICALS, INC.   |  ALLAY THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-09-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-22 
2014-09-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-01-08 
2012-03-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-01-08 
2010-01-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-01-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#